Lapatinib in combination with capecitabine versus continued use of trastuzumab in breast cancer patients with trastuzumab-resistance: a retrospective study of a Chinese population.
Yang F, Huang X, Sun C, Li J, Wang B, Yan M, Jin F, Wang H, Zhang J, Fu P, Zeng T, Wang J, Li W, Li Y, Yang M, Li J, Wu H, Fu Z, Yin Y, Jiang Z.
Yang F, et al. Among authors: li y, li j, li w.
BMC Cancer. 2020 Mar 29;20(1):255. doi: 10.1186/s12885-020-6639-4.
BMC Cancer. 2020.
PMID: 32223744
Free PMC article.